Brow Enhancement Study

Brow Ptosis Clinical Trial

Official title:

Investigation Into Brow Aesthetics Using Botox in Conjunction With Juvederm Ultra XC as Evaluated by Patient Satisfaction

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01308593
• Other study ID #: Brow Study 25856/1
• Status: Completed
• Phase: Phase 4
• First received: March 2, 2011
• Last updated: January 3, 2013
• Start date: March 2011
• Est. completion date: October 2011

Study information

• Verified date: January 2013
• Source: Skin Care and Laser Physicians of Beverly Hills
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

Investigation into brow aesthetics using Botox in Conjunction with Juvederm XC as evaluated by patient satisfaction

Recruitment information / eligibility

• Status: Completed
• Enrollment: 30
• Est. completion date: October 2011
• Est. primary completion date: October 2011
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• Men and women

Exclusion Criteria:

• Persons who have not had Botox for months.

• Women who are pregnant, breastfeeding, or trying to get pregnant.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Brow Ptosis

Intervention

Device:
• Juvederm XC
Filler

Drug:
• Botox
26 units dosed one time

Locations

Country	Name	City	State
United States	Skin Care and Laser Physicians of Beverly Hills	Los Angeles	California

Sponsors (1)

Lead Sponsor	Collaborator
Skin Care and Laser Physicians of Beverly Hills

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Participant satisfaction with combined injection with Botox and Juvederm XC		5 months	No